<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="other"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Open Res Eur</journal-id><journal-id journal-id-type="iso-abbrev">Open Res Eur</journal-id><journal-title-group><journal-title>Open Research Europe</journal-title></journal-title-group><issn pub-type="epub">2732-5121</issn><publisher><publisher-name>F1000 Research Limited</publisher-name><publisher-loc>London, UK</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40013102</article-id><article-id pub-id-type="pmc">PMC11862357</article-id><article-id pub-id-type="doi">10.12688/openreseurope.19281.1</article-id><article-categories><subj-group subj-group-type="heading"><subject>Study Protocol</subject></subj-group><subj-group><subject>Articles</subject></subj-group></article-categories><title-group><article-title>Relationship between
<italic toggle="yes">Blastocystis</italic> infection and clinical outcomes: A scoping review protocol</article-title><fn-group content-type="pub-status"><fn><p>[version 1; peer review: 3 approved]</p></fn></fn-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Tunali</surname><given-names>Varol</given-names></name><role content-type="http://credit.niso.org/">Conceptualization</role><role content-type="http://credit.niso.org/">Data Curation</role><role content-type="http://credit.niso.org/">Formal Analysis</role><role content-type="http://credit.niso.org/">Funding Acquisition</role><role content-type="http://credit.niso.org/">Investigation</role><role content-type="http://credit.niso.org/">Methodology</role><role content-type="http://credit.niso.org/">Project Administration</role><role content-type="http://credit.niso.org/">Resources</role><role content-type="http://credit.niso.org/">Supervision</role><role content-type="http://credit.niso.org/">Validation</role><role content-type="http://credit.niso.org/">Visualization</role><role content-type="http://credit.niso.org/">Writing &#x02013; Original Draft Preparation</role><role content-type="http://credit.niso.org/">Writing &#x02013; Review &#x00026; Editing</role><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1799-2539</contrib-id><xref rid="c1" ref-type="corresp">a</xref><xref rid="a1" ref-type="aff">1</xref><xref rid="a2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Nagavci</surname><given-names>Blin</given-names></name><role content-type="http://credit.niso.org/">Investigation</role><role content-type="http://credit.niso.org/">Methodology</role><role content-type="http://credit.niso.org/">Project Administration</role><role content-type="http://credit.niso.org/">Software</role><role content-type="http://credit.niso.org/">Supervision</role><role content-type="http://credit.niso.org/">Validation</role><role content-type="http://credit.niso.org/">Writing &#x02013; Review &#x00026; Editing</role><xref rid="a3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name><surname>Carmena</surname><given-names>David</given-names></name><role content-type="http://credit.niso.org/">Formal Analysis</role><role content-type="http://credit.niso.org/">Validation</role><role content-type="http://credit.niso.org/">Writing &#x02013; Review &#x00026; Editing</role><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4015-8553</contrib-id><xref rid="a4" ref-type="aff">4</xref><xref rid="a5" ref-type="aff">5</xref></contrib><contrib contrib-type="author"><name><surname>Robertson</surname><given-names>Lucy J.</given-names></name><role content-type="http://credit.niso.org/">Formal Analysis</role><role content-type="http://credit.niso.org/">Visualization</role><role content-type="http://credit.niso.org/">Writing &#x02013; Review &#x00026; Editing</role><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5186-4421</contrib-id><xref rid="a6" ref-type="aff">6</xref></contrib><contrib contrib-type="author"><name><surname>Do&#x0011f;ruman Al</surname><given-names>Funda</given-names></name><role content-type="http://credit.niso.org/">Data Curation</role><role content-type="http://credit.niso.org/">Formal Analysis</role><role content-type="http://credit.niso.org/">Funding Acquisition</role><role content-type="http://credit.niso.org/">Supervision</role><role content-type="http://credit.niso.org/">Visualization</role><role content-type="http://credit.niso.org/">Writing &#x02013; Review &#x00026; Editing</role><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9118-3935</contrib-id><xref rid="a7" ref-type="aff">7</xref></contrib><contrib contrib-type="author"><name><surname>Gentekaki</surname><given-names>Eleni</given-names></name><role content-type="http://credit.niso.org/">Formal Analysis</role><role content-type="http://credit.niso.org/">Funding Acquisition</role><role content-type="http://credit.niso.org/">Resources</role><role content-type="http://credit.niso.org/">Supervision</role><role content-type="http://credit.niso.org/">Writing &#x02013; Review &#x00026; Editing</role><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3306-6714</contrib-id><xref rid="a8" ref-type="aff">8</xref></contrib><contrib contrib-type="author"><name><surname>Tsaousis</surname><given-names>Anastasios D.</given-names></name><role content-type="http://credit.niso.org/">Formal Analysis</role><role content-type="http://credit.niso.org/">Funding Acquisition</role><role content-type="http://credit.niso.org/">Resources</role><role content-type="http://credit.niso.org/">Supervision</role><role content-type="http://credit.niso.org/">Visualization</role><role content-type="http://credit.niso.org/">Writing &#x02013; Review &#x00026; Editing</role><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5424-1905</contrib-id><xref rid="a9" ref-type="aff">9</xref></contrib><aff id="a1">
<label>1</label>Department of Microbiology, Izmir University of Economics, Izmir, Turkey</aff><aff id="a2">
<label>2</label>Department of Emergency Medicine, Izmir Metropolitan Municipality E&#x0015f;refpa&#x0015f;a Hospital, Izmir, Turkey</aff><aff id="a3">
<label>3</label>Doctoral School of Clinical Medicine, Semmelweis University, Budapest, Budapest, Hungary</aff><aff id="a4">
<label>4</label>Spanish National Centre for Microbiology, Health Institute Carlos III, Parasitology Reference and Research Laboratory, Majadahonda, Madrid, Spain</aff><aff id="a5">
<label>5</label>Centre for Biomedical Research Network in Infectious Diseases (CIBERINFEC), Health Institute Carlos III, Madrid, Spain</aff><aff id="a6">
<label>6</label>Faculty of Veterinary Medicine, Norwegian University of Life Sciences, &#x000c5;s, Norway</aff><aff id="a7">
<label>7</label>Faculty of Medicine, Department of Medical Microbiology, Division of Medical Parasitology, Gazi University, Ankara, Turkey</aff><aff id="a8">
<label>8</label>Department of Veterinary Medicine, University of Nicosia, Nicosia, Nicosia, Cyprus</aff><aff id="a9">
<label>9</label>School of Natural Sciences, University of Kent, Canterbury, England, UK</aff></contrib-group><author-notes><corresp id="c1">
<label>a</label>
<email xlink:href="mailto:varoltunali@gmail.com">varoltunali@gmail.com</email>
</corresp><fn fn-type="COI-statement"><p>No competing interests were disclosed.</p></fn></author-notes><pub-date pub-type="epub"><day>20</day><month>1</month><year>2025</year></pub-date><pub-date pub-type="collection"><year>2025</year></pub-date><volume>5</volume><elocation-id>15</elocation-id><history><date date-type="accepted"><day>6</day><month>1</month><year>2025</year></date></history><permissions><copyright-statement>Copyright: &#x000a9; 2025 Tunali V et al.</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="openreseurope-5-20870.pdf"/><abstract><p>
<italic toggle="yes">Blastocystis</italic>, a common protist in the human gastrointestinal tract, exhibits substantial genetic diversity and has been linked to varying clinical outcomes. However, its role in human health remains debated, with studies suggesting both commensal and pathogenic interactions. This scoping review aims to systematically map the existing evidence on the association between
<italic toggle="yes">Blastocystis</italic> presence and human clinical outcomes. Herein, we present our proposed protocol, where, using systematic search methods, studies will be identified from multiple databases, focusing on diagnostic procedures, clinical outcomes, and treatment options. Findings will provide a comprehensive evidence map, highlighting knowledge gaps and guiding future research. The resulting data is intended to inform clinical and public health perspectives on
<italic toggle="yes">Blastocystis</italic> and its potential implications for human health.</p></abstract><abstract abstract-type="plain-language-summary"><title>Plain language summary</title><p>Blastocystis, a common protist in the human gastrointestinal tract, exhibits substantial genetic diversity and has been linked to varying clinical outcomes. However, its role in human health remains debated, with studies suggesting both commensal and pathogenic interactions. This scoping review aims to systematically map the existing evidence on the association between Blastocystis presence and human clinical outcomes. Herein, we present our proposed protocol, where, using systematic search methods, studies will be identified from multiple databases, focusing on diagnostic procedures, clinical outcomes, and treatment options. Findings will provide a comprehensive evidence map, highlighting knowledge gaps and guiding future research. The resulting data is intended to inform clinical and public health perspectives on Blastocystis and its potential implications for human health</p></abstract><kwd-group kwd-group-type="author"><kwd>Gut microbiota</kwd><kwd>Diagnostic methods</kwd><kwd>Subtype diversity</kwd><kwd>Intestinal health</kwd></kwd-group><funding-group><award-group id="fund-1" xlink:href="http://dx.doi.org/10.13039/100018693"><funding-source>Horizon Europe Framework Programme</funding-source><award-id>CA21105</award-id></award-group><award-group id="fund-2" xlink:href="https://doi.org/10.13039/501100000921"><funding-source>European Cooperation in Science and Technology</funding-source><award-id>CA21105</award-id></award-group><funding-statement>Varol TUNALI received funding from COST Action "CA21105, Blastocystis under One Health" for this work.</funding-statement></funding-group></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>
<italic toggle="yes">Blastocystis</italic>, a protist commonly found in the human gastrointestinal tract, is one of the most prevalent eukaryotic microorganisms globally
<sup>
<xref rid="ref-1" ref-type="bibr">1</xref>
</sup>. It exhibits significant genetic diversity, with at least 44 subtypes (STs) identified to date based on sequence analyses of the small subunit ribosomal RNA (
<italic toggle="yes">SSU</italic> rRNA) gene
<sup>
<xref rid="ref-2" ref-type="bibr">2</xref>,
<xref rid="ref-3" ref-type="bibr">3</xref>
</sup>. Among these, ST1-ST10, ST12, ST14, ST16, ST23, ST35, and ST41 have been reported from humans, with ST1 to ST4 being the most frequently identified
<sup>
<xref rid="ref-4" ref-type="bibr">4</xref>,
<xref rid="ref-5" ref-type="bibr">5</xref>
</sup>. The interaction of
<italic toggle="yes">Blastocystis</italic> with the gut microbiota and the host immune system has been linked to a range of clinical outcomes, highlighting its potential relevance to human health
<sup>
<xref rid="ref-6" ref-type="bibr">6</xref>
</sup>.</p><p>
<italic toggle="yes">Blastocystis</italic> is distributed worldwide, with varying occurrence rates across different regions. It has been reported globally, with variations likely influenced by differences in sanitation and hygiene practices
<sup>
<xref rid="ref-7" ref-type="bibr">7</xref>
</sup>.
<italic toggle="yes">Blastocystis</italic> is found to be present in both healthy individuals and those experiencing gastrointestinal symptoms. Some studies have reported associations between symptoms such as diarrhea, abdominal pain, bloating, and the presence of
<italic toggle="yes">Blastocystis</italic>
<sup>
<xref rid="ref-8" ref-type="bibr">8</xref>
</sup>. However, these associations are inconsistent across studies, and the public health significance of
<italic toggle="yes">Blastocystis</italic> remains uncertain, primarily due to conflicting evidence regarding its role in health and disease.</p><p>The clinical significance of
<italic toggle="yes">Blastocystis</italic> has been a topic of ongoing debate. Historically considered a parasitic organism, some studies have questioned whether certain subtypes or host interactions might contribute to health outcomes in specific contexts
<sup>
<xref rid="ref-9" ref-type="bibr">9</xref>
</sup>. The genetic diversity of
<italic toggle="yes">Blastocystis</italic> adds complexity, with some subtypes being more frequently detected in symptomatic individuals, while others are commonly found in asymptomatic populations. The interplay between
<italic toggle="yes">Blastocystis</italic>, the host immune response, and the gut microbiota is believed to play a critical role in determining its impact on human health
<sup>
<xref rid="ref-10" ref-type="bibr">10</xref>
</sup>.</p><p>The existing literature presents diverse perspectives on
<italic toggle="yes">Blastocystis</italic>. Some studies suggest that
<italic toggle="yes">Blastocystis</italic> presence may be associated with beneficial changes in the gut microbiota, such as increased bacterial diversity and anti-inflammatory responses
<sup>
<xref rid="ref-8" ref-type="bibr">8</xref>
</sup>. Conversely, some studies report that
<italic toggle="yes">Blastocystis</italic> may be associated with reduced beneficial bacteria and an altered gut microbiome composition
<sup>
<xref rid="ref-11" ref-type="bibr">11</xref>
</sup>. Given the conflicting evidence regarding the pathogenicity of
<italic toggle="yes">Blastocystis</italic>, a comprehensive scoping review is warranted to systematically map the existing evidence. This review will synthesize original research studies on human subjects, focusing on the association between
<italic toggle="yes">Blastocystis</italic> presence and various clinical outcomes.</p><sec><title>Objectives</title><p>The primary objective of this scoping review is to systematically map the existing evidence on
<italic toggle="yes">Blastocystis</italic> presence and clinical outcomes in humans. This review will help clarify the current state of knowledge, identify research gaps, and provide a foundation for future studies that can further explore this relationship. The following research questions will be assessed:</p><list list-type="simple"><list-item><label>1. </label><p>What evidence exists on the relationship between
<italic toggle="yes">Blastocystis</italic> occurrence and human clinical outcomes?</p></list-item><list-item><label>2. </label><p>What evidence exists regarding the diagnostic methods used for
<italic toggle="yes">Blastocystis</italic> detection, and their performance and accuracy?</p></list-item><list-item><label>3. </label><p>What evidence is available on the treatment and management options for
<italic toggle="yes">Blastocystis</italic>?</p></list-item></list></sec></sec><sec sec-type="methods"><title>Methods</title><p>This scoping review will be conducted and reported in accordance with the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) extension for scoping reviews (PRISMA-ScR)
<sup>
<xref rid="ref-12" ref-type="bibr">12</xref>
</sup>.</p><sec><title>Literature searches</title><p>Systematic searches for relevant published studies will be conducted in PubMed, EMBASE, Web of Science, and the Cochrane Library. An experienced methodologist will develop and validate search strategies to ensure maximum sensitivity. Searches will be performed without time restrictions, and the date of the search, search strategy, and number of search results will be documented for each database.</p></sec><sec><title>Selection of studies</title><p>The selection process will involve two stages: screening and eligibility assessment. Titles and abstracts will be screened by two independent reviewers to identify potentially relevant studies, using Rayyan. Full-text articles of studies deemed relevant will be retrieved and assessed for eligibility based on predefined criteria, by two reviewers. Disagreements will be resolved through discussion or by consulting a third reviewer. Screening results and reasons for exclusion will be documented in PRISMA flowcharts.</p></sec><sec><title>Eligibility criteria</title><p>To be included in this scoping review, studies must involve human participants with confirmed (or, for the diagnostic question, suspected)
<italic toggle="yes">Blastocystis</italic> infection. To be a confirmed case, the infection must be diagnosed using reliable methods such as direct microscopy, culture, conventional and qPCR, or next-generation sequencing (NGS). Studies that primarily focus on other parasitic infections, where
<italic toggle="yes">Blastocystis</italic> is not the main focus, will be excluded.</p><p>Studies that include both symptomatic and asymptomatic individuals with
<italic toggle="yes">Blastocystis</italic> infection will be eligible, as this should assist in providing a comprehensive understanding of the organism&#x02019;s potential pathogenicity and its association with various clinical outcomes (
<xref rid="T1" ref-type="table">Table 1</xref>).</p><table-wrap position="anchor" id="T1"><label>Table 1. </label><caption><title>Inclusion and exclusion criteria for each research question.</title></caption><table frame="hsides" rules="groups" content-type="article-table"><thead><tr><th align="left" colspan="1" rowspan="1" valign="top"/><th align="left" colspan="1" rowspan="1" valign="top">Research Question</th><th align="left" colspan="1" rowspan="1" valign="top">Population</th><th align="left" colspan="1" rowspan="1" valign="top">Exposure</th><th align="left" colspan="1" rowspan="1" valign="top">Comparator</th><th align="left" colspan="1" rowspan="1" valign="top">Outcomes</th><th align="left" colspan="1" rowspan="1" valign="top">Study Design</th><th align="left" colspan="1" rowspan="1" valign="top">Exclusion criteria</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1" valign="top">1</td><td align="left" colspan="1" rowspan="1" valign="top">What evidence exists
<break/>on the relationship
<break/>between Blastocystis
<break/>infection and clinical
<break/>outcomes, and
<break/>pathogenicity in
<break/>humans?</td><td align="left" colspan="1" rowspan="1" valign="top">Humans of all ages</td><td align="left" colspan="1" rowspan="1" valign="top">
<italic toggle="yes">Blastocystis</italic> infection </td><td align="left" colspan="1" rowspan="1" valign="top">No
<italic toggle="yes">Blastocystis</italic>
<break/>infection</td><td align="left" colspan="1" rowspan="1" valign="top">All reported clinical
<break/>outcomes (e.g.,
<break/>gastrointestinal/extra-
<break/>intestinal symptoms,
<break/>pathogenicity etc.) </td><td align="left" colspan="1" rowspan="1" valign="top">Cross-sectional,
<break/>cohort studies,
<break/>case-control studies,
<break/>prevalence studies,
<break/>systematic reviews.</td><td align="left" colspan="1" rowspan="7" valign="top">
<bold>Study Type</bold>: Editorials,
<break/>letters, commentaries,
<break/>conference abstracts,
<break/>case series, case reports,
<break/>clinical guidelines,
<break/>narrative reviews (though
<break/>reference lists will be
<break/>screened), and non-peer-
<break/>reviewed works (e.g.,
<break/>theses, preprints).
<break/>
<bold>Subject</bold>: Animal studies
<break/>or research conducted
<break/>solely in non-human
<break/>settings (e.g., laboratory/
<break/>animal models).
<break/>
<bold>Confirmation</bold>: Studies
<break/>where Blastocystis
<break/>infection is neither
<break/>confirmed nor suspected.
<break/>Results: Studies reporting
<break/>combined treatment
<break/>outcomes without
<break/>
<italic toggle="yes">Blastocystis</italic>-specific
<break/>results
<break/>
<bold>Focus</bold>: Studies where
<break/>
<italic toggle="yes">Blastocystis</italic> is not the
<break/>main focus, including
<break/>those primarily
<break/>addressing other
<break/>parasitic infections or
<break/>treatments not targeting
<break/>
<italic toggle="yes">Blastocystis</italic> specifically.
<break/>
<bold>Language</bold>: Except
<break/>English, Greek, Spanish,
<break/>German, French,
<break/>Norwegian, Danish,
<break/>Russian, and Turkish.</td></tr><tr><th align="left" colspan="1" rowspan="1" valign="top"/><th align="left" colspan="1" rowspan="1" valign="top">Research Question</th><th align="left" colspan="1" rowspan="1" valign="top">Population</th><th align="left" colspan="1" rowspan="1" valign="top">Index Test</th><th align="left" colspan="1" rowspan="1" valign="top">Reference Test</th><th align="left" colspan="1" rowspan="1" valign="top">Outcomes</th><th align="left" colspan="1" rowspan="1" valign="top">Study Design</th></tr><tr><td align="left" colspan="1" rowspan="1" valign="top">2</td><td align="left" colspan="1" rowspan="1" valign="top">What evidence
<break/>exists regarding the
<break/>diagnostic methods
<break/>used for
<italic toggle="yes">Blastocystis</italic>
<break/>diagnosis, and their
<break/>performance?</td><td align="left" colspan="1" rowspan="1" valign="top">Humans of all
<break/>ages suspected of
<break/>Blastocystis infection</td><td align="left" colspan="1" rowspan="1" valign="top">Diagnostic methods
<break/>(e.g., microscopy,
<break/>culture, molecular
<break/>diagnostics)</td><td align="left" colspan="1" rowspan="1" valign="top">Any reference
<break/>standard or
<break/>another diagnostic
<break/>method</td><td align="left" colspan="1" rowspan="1" valign="top">All reported test
<break/>accuracy outcomes.</td><td align="left" colspan="1" rowspan="1" valign="top">Diagnostic accuracy
<break/>studies, clinical trials,
<break/>systematic reviews.</td></tr><tr><th align="left" colspan="1" rowspan="1" valign="top"/><th align="left" colspan="1" rowspan="1" valign="top">Research Question</th><th align="left" colspan="1" rowspan="1" valign="top">Population</th><th align="left" colspan="1" rowspan="1" valign="top">Intervention</th><th align="left" colspan="1" rowspan="1" valign="top">Comparator</th><th align="left" colspan="1" rowspan="1" valign="top">Outcomes</th><th align="left" colspan="1" rowspan="1" valign="top">Study Design</th></tr><tr><td align="left" colspan="1" rowspan="1" valign="top">3</td><td align="left" colspan="1" rowspan="1" valign="top">What evidence is
<break/>available on the
<break/>treatment options for
<break/>
<italic toggle="yes">Blastocystis</italic> infection,
<break/>and how effective are
<break/>these interventions
<break/>in managing the
<break/>infection and
<break/>associated symptoms?</td><td align="left" colspan="1" rowspan="1" valign="top">Humans of all ages
<break/>with confirmed
<break/>
<italic toggle="yes">Blastocystis</italic> infection</td><td align="left" colspan="1" rowspan="1" valign="top">Any treatment for
<break/>
<italic toggle="yes">Blastocystis</italic>
</td><td align="left" colspan="1" rowspan="1" valign="top">No treatment,
<break/>placebo, or
<break/>alternative
<break/>strategies</td><td align="left" colspan="1" rowspan="1" valign="top">All reported outcomes
<break/>(e.g. eradication of
<break/>
<italic toggle="yes">Blastocystis</italic>, symptom
<break/>resolution etc.)</td><td align="left" colspan="1" rowspan="1" valign="top">Clinical trials, cross-
<break/>sectional, cohort
<break/>studies, case-control
<break/>studies, systematic
<break/>reviews.</td></tr></tbody></table></table-wrap><p>Studies published in all languages spoken by the panel members will be considered (English, Greek, Spanish, German, French, Norwegian, Danish, Russian, and Turkish), in order to maximize data capture.</p><p>Eligible study types include randomized and non-randomized trials, cohort studies, case-control, systematic reviews, and cross-sectional studies (with or without a control group). Editorials, letters, commentaries, conference abstracts, case series, case reports, clinical guidelines, narrative reviews, and non-peer-reviewed work (e.g. theses), will be excluded. Narrative review articles will not be included, but their reference lists will be explored for further data sources (
<xref rid="T1" ref-type="table">Table 1</xref>).</p><p>No date limit will be used for the inclusion criteria, in order to provide a full evidence map on this topic.</p></sec><sec><title>Data extraction</title><p>Data from included studies will be charted using a standardized data extraction form. The form will be piloted to ensure consistency and reliability. Data extraction will be performed independently by two reviewers, with cross-checking to resolve discrepancies. Additional data or clarifications will be sought from study authors when required.</p></sec><sec><title>Data items</title><p>The data items to be extracted will include:</p><list list-type="bullet"><list-item><p>Study Characteristics: Author, year of publication, study type, design, setting, and geographical location.</p></list-item><list-item><p>Population Details: Number of participants, age, gender</p></list-item><list-item><p>Details of
<italic toggle="yes">Blastocystis</italic> Infection: Detection methods used, subtype identification, presence or absence of symptoms.</p></list-item><list-item><p>Clinical Outcomes: All reported symptoms (including gastrointestinal, dermatologic etc. symptoms), associations with
<italic toggle="yes">Blastocystis</italic> subtypes (if reported), any given treatment and treatment outcome, and any other clinically relevant outcome</p></list-item><list-item><p>Subgroups: studies will be presented in subgroups based on study design and patient population.</p></list-item></list></sec></sec><sec sec-type="results"><title>Results</title><p>The results section will describe the evidence of the relationship between
<italic toggle="yes">Blastocystis</italic> infection and clinical outcomes, variations in outcomes based on diagnostic methods, and the pathogenicity of specific
<italic toggle="yes">Blastocystis</italic> subtypes. Identified and included studies will be presented in both tabular and graphical forms, offering a complete evidence map on this topic. Research gaps will also be identified, and recommendations for future studies will be provided. </p><sec><title>Critical appraisal of individual sources of evidence</title><p>As critical appraisal is not a mandatory step in scoping reviews, it is not planned to be conducted.</p></sec></sec><sec sec-type="discussion | conclusions"><title>Discussion and conclusions</title><p>The findings of this scoping review will provide a comprehensive synthesis of the current evidence on
<italic toggle="yes">Blastocystis's</italic> potential associations with clinical outcomes. Despite its high prevalence and global distribution,
<italic toggle="yes">Blastocystis</italic> remains poorly understood, with conflicting perspectives regarding its clinical relevance
<sup>
<xref rid="ref-13" ref-type="bibr">13</xref>
</sup>.</p><p>In conclusion, this scoping review aims to serve as a foundational resource for researchers and clinicians, guiding the design of targeted studies and providing a robust evidence base for
<italic toggle="yes">Blastocystis</italic> research.</p></sec><sec><title>Ethics and consent</title><p>Ethics and consent were not required.</p></sec></body><back><sec sec-type="data-availability"><title>Data availability statement</title><p>No data are associated with this article</p></sec><ref-list><ref id="ref-1"><label>1</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Stensvold</surname><given-names>CR</given-names></name>
</person-group>:
<article-title>Thinking
<italic toggle="yes">Blastocystis</italic> out of the box.</article-title>
<source>
<italic toggle="yes">Trends Parasitol.</italic>
</source>
<year>2012</year>;<volume>28</volume>(<issue>8</issue>):<fpage>305</fpage>.
<pub-id pub-id-type="doi">10.1016/j.pt.2012.05.004</pub-id>
<pub-id pub-id-type="pmid">22704911</pub-id>
</mixed-citation></ref><ref id="ref-2"><label>2</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Maloney</surname><given-names>JG</given-names></name>
<name><surname>Molokin</surname><given-names>A</given-names></name>
<name><surname>Segu&#x000ed;</surname><given-names>R</given-names></name>
<etal/>
</person-group>:
<article-title>Identification and molecular characterization of four new
<italic toggle="yes">Blastocystis</italic> subtypes designated ST35-ST38.</article-title>
<source>
<italic toggle="yes">Microorganisms.</italic>
</source>
<year>2023</year>;<volume>11</volume>(<issue>1</issue>):<fpage>46</fpage>.
<pub-id pub-id-type="doi">10.3390/MICROORGANISMS11010046</pub-id>
<!--<pub-id pub-id-type="pmcid">9860945</pub-id>-->
<pub-id pub-id-type="pmid">36677338</pub-id>
</mixed-citation></ref><ref id="ref-3"><label>3</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Koehler</surname><given-names>AV</given-names></name>
<name><surname>Herath HMPD, Hall</surname><given-names>RS</given-names></name>
<etal/>
</person-group>:
<article-title>Marked genetic diversity within
<italic toggle="yes">Blastocystis</italic> in Australian wildlife revealed using a next generation sequencing-phylogenetic approach.</article-title>
<source>
<italic toggle="yes">Int J Parasitol Parasites Wildl.</italic>
</source>
<year>2024</year>;<volume>23</volume>:
<elocation-id>100902</elocation-id>.
<pub-id pub-id-type="doi">10.1016/J.IJPPAW.2023.100902</pub-id>
<!--<pub-id pub-id-type="pmcid">10827504</pub-id>-->
<pub-id pub-id-type="pmid">38292245</pub-id>
</mixed-citation></ref><ref id="ref-4"><label>4</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Jinatham</surname><given-names>V</given-names></name>
<name><surname>Yowang</surname><given-names>A</given-names></name>
<name><surname>Stensvold</surname><given-names>CR</given-names></name>
<etal/>
</person-group>:
<article-title>
<italic toggle="yes">Blastocystis</italic> colonization and associations with population parameters in Thai adults.</article-title>
<source>
<italic toggle="yes">PLoS Negl Trop Dis.</italic>
</source>
<year>2024</year>;<volume>18</volume>(<issue>7</issue>):
<elocation-id>e0012292</elocation-id>.
<pub-id pub-id-type="doi">10.1371/JOURNAL.PNTD.0012292</pub-id>
<!--<pub-id pub-id-type="pmcid">11259296</pub-id>-->
<pub-id pub-id-type="pmid">38980911</pub-id>
</mixed-citation></ref><ref id="ref-5"><label>5</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Hern&#x000e1;ndez-Castro</surname><given-names>C</given-names></name>
<name><surname>Maloney</surname><given-names>JG</given-names></name>
<name><surname>Agudelo-L&#x000f3;pez</surname><given-names>SP</given-names></name>
<etal/>
</person-group>:
<article-title>Identification and validation of novel
<italic toggle="yes">Blastocystis</italic> subtype ST41 in a Colombian patient undergoing colorectal cancer screening.</article-title>
<source>
<italic toggle="yes">J Eukaryot Microbiol.</italic>
</source>
<year>2023</year>;<volume>70</volume>(<issue>5</issue>):
<elocation-id>e12978</elocation-id>.
<pub-id pub-id-type="doi">10.1111/JEU.12978</pub-id>
<pub-id pub-id-type="pmid">37195413</pub-id>
</mixed-citation></ref><ref id="ref-6"><label>6</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Deng</surname><given-names>L</given-names></name>
<name><surname>Wojciech</surname><given-names>L</given-names></name>
<name><surname>Gascoigne</surname><given-names>NRJ</given-names></name>
<etal/>
</person-group>:
<article-title>New insights into the interactions between
<italic toggle="yes">Blastocystis</italic>, the gut microbiota, and host immunity.</article-title>
<source>
<italic toggle="yes">PLoS Pathog.</italic>
</source>
<year>2021</year>;<volume>17</volume>(<issue>2</issue>):
<elocation-id>e1009253</elocation-id>.
<pub-id pub-id-type="doi">10.1371/JOURNAL.PPAT.1009253</pub-id>
<!--<pub-id pub-id-type="pmcid">7906322</pub-id>-->
<pub-id pub-id-type="pmid">33630979</pub-id>
</mixed-citation></ref><ref id="ref-7"><label>7</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>El Safadi</surname><given-names>D</given-names></name>
<name><surname>Gaayeb</surname><given-names>L</given-names></name>
<name><surname>Meloni</surname><given-names>D</given-names></name>
<etal/>
</person-group>:
<article-title>Children of senegal river basin show the highest prevalence of
<italic toggle="yes">Blastocystis</italic> sp. ever observed worldwide.</article-title>
<source>
<italic toggle="yes">BMC Infect Dis.</italic>
</source>
<year>2014</year>;<volume>14</volume>: 164.
<pub-id pub-id-type="doi">10.1186/1471-2334-14-164</pub-id>
<!--<pub-id pub-id-type="pmcid">3987649</pub-id>-->
<pub-id pub-id-type="pmid">24666632</pub-id>
</mixed-citation></ref><ref id="ref-8"><label>8</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Boorom</surname><given-names>KF</given-names></name>
<name><surname>Smith</surname><given-names>H</given-names></name>
<name><surname>Nimri</surname><given-names>L</given-names></name>
<etal/>
</person-group>:
<article-title>Oh my aching gut: irritable bowel syndrome,
<italic toggle="yes">Blastocystis</italic>, and asymptomatic infection.</article-title>
<source>
<italic toggle="yes">Parasit Vectors.</italic>
</source>
<year>2008</year>;<volume>1</volume>(<issue>1</issue>): 40.
<pub-id pub-id-type="doi">10.1186/1756-3305-1-40</pub-id>
<!--<pub-id pub-id-type="pmcid">2627840</pub-id>-->
<pub-id pub-id-type="pmid">18937874</pub-id>
</mixed-citation></ref><ref id="ref-9"><label>9</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Ajjampur</surname><given-names>SSR</given-names></name>
<name><surname>Tan</surname><given-names>KSW</given-names></name>
</person-group>:
<article-title>Pathogenic mechanisms in
<italic toggle="yes">Blastocystis</italic> spp. &#x02014; Interpreting results from
<italic toggle="yes">in vitro</italic> and
<italic toggle="yes">in vivo</italic> studies.</article-title>
<source>
<italic toggle="yes">Parasitol Int.</italic>
</source>
<year>2016</year>;<volume>65</volume>(<issue>6 Pt B</issue>):<fpage>772</fpage>&#x02013;<lpage>9</lpage>.
<pub-id pub-id-type="doi">10.1016/J.PARINT.2016.05.007</pub-id>
<pub-id pub-id-type="pmid">27181702</pub-id>
</mixed-citation></ref><ref id="ref-10"><label>10</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Aykur</surname><given-names>M</given-names></name>
<name><surname>Malatyal&#x00131;</surname><given-names>E</given-names></name>
<name><surname>Demirel</surname><given-names>F</given-names></name>
<etal/>
</person-group>:
<article-title>
<italic toggle="yes">Blastocystis</italic>: a mysterious member of the gut microbiome.</article-title>
<source>
<italic toggle="yes">Microorganisms.</italic>
</source>
<year>2024</year>;<volume>12</volume>(<issue>3</issue>):<fpage>461</fpage>.
<pub-id pub-id-type="doi">10.3390/MICROORGANISMS12030461</pub-id>
<!--<pub-id pub-id-type="pmcid">10972062</pub-id>-->
<pub-id pub-id-type="pmid">38543512</pub-id>
</mixed-citation></ref><ref id="ref-11"><label>11</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Yason</surname><given-names>JA</given-names></name>
<name><surname>Liang</surname><given-names>YR</given-names></name>
<name><surname>Png</surname><given-names>CW</given-names></name>
<etal/>
</person-group>:
<article-title>Interactions between a pathogenic
<italic toggle="yes">Blastocystis</italic> subtype and gut microbiota:
<italic toggle="yes">in vitro</italic> and
<italic toggle="yes">in vivo</italic> studies.</article-title>
<source>
<italic toggle="yes">Microbiome.</italic>
</source>
<year>2019</year>;<volume>7</volume>(<issue>1</issue>): 30.
<pub-id pub-id-type="doi">10.1186/S40168-019-0644-3</pub-id>
<!--<pub-id pub-id-type="pmcid">6410515</pub-id>-->
<pub-id pub-id-type="pmid">30853028</pub-id>
</mixed-citation></ref><ref id="ref-12"><label>12</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Tricco</surname><given-names>AC</given-names></name>
<name><surname>Lillie</surname><given-names>E</given-names></name>
<name><surname>Zarin</surname><given-names>W</given-names></name>
<etal/>
</person-group>:
<article-title>PRISMA extension for Scoping Reviews (PRISMA-ScR): checklist and explanation.</article-title>
<source>
<italic toggle="yes">Ann Intern Med.</italic>
</source>
<year>2018</year>;<volume>169</volume>(<issue>7</issue>):<fpage>467</fpage>&#x02013;<lpage>73</lpage>.
<pub-id pub-id-type="doi">10.7326/M18-0850</pub-id>
<pub-id pub-id-type="pmid">30178033</pub-id>
</mixed-citation></ref><ref id="ref-13"><label>13</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Tsaousis</surname><given-names>AD</given-names></name>
<name><surname>Gentekaki</surname><given-names>E</given-names></name>
<name><surname>Stensvold</surname><given-names>CR</given-names></name>
</person-group>:
<article-title>Advancing research on
<italic toggle="yes">Blastocystis</italic> through a One Health approach [version 1; peer review: 3 approved].</article-title>
<source>
<italic toggle="yes">Open Res Eur.</italic>
</source>
<year>2024</year>;<volume>4</volume>:<fpage>145</fpage>.
<pub-id pub-id-type="doi">10.12688/openreseurope.18046.1</pub-id>
<!--<pub-id pub-id-type="pmcid">11294803</pub-id>-->
<pub-id pub-id-type="pmid">39100073</pub-id>
</mixed-citation></ref></ref-list></back><sub-article article-type="reviewer-report" id="report50442"><front-stub><article-id pub-id-type="doi">10.21956/openreseurope.20870.r50442</article-id><title-group><article-title>Reviewer response for version 1</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Popruk</surname><given-names>Supaluk</given-names></name><xref rid="r50442a1" ref-type="aff">1</xref><role>Referee</role></contrib><aff id="r50442a1">
<label>1</label>Mahidol University, Bangkok, Thailand</aff></contrib-group><author-notes><fn fn-type="COI-statement"><p>
<bold>Competing interests: </bold>No competing interests were disclosed.</p></fn></author-notes><pub-date pub-type="epub"><day>26</day><month>2</month><year>2025</year></pub-date><permissions><copyright-statement>Copyright: &#x000a9; 2025 Popruk S</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access peer review report distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><related-article related-article-type="peer-reviewed-article" ext-link-type="doi" id="relatedArticleReport50442" xlink:href="10.12688/openreseurope.19281.1">Version 1</related-article><custom-meta-group><custom-meta><meta-name>recommendation</meta-name><meta-value>approve</meta-value></custom-meta></custom-meta-group></front-stub><body><p>This study offers valuable information for conducting a systematic review and meta-analysis. Additionally, the methodology outlined can guide future studies in replicating or expanding upon the results. Furthermore, the study can serve as a foundation for evidence-based data, which can inform future research directions and can be the guidelines for other parasites or pathogens. The article exhibits a notable weakness in that it lacks a clear delineation of participant types, such as children, villagers, individuals with close contact to animals, and caregivers. The inclusion of these distinct groups may have led to different outcomes.</p><p> However, the strengths of this article are guidelines of the related research in systematic review and meta-analysis.</p><p>Is the study design appropriate for the research question?</p><p>Yes</p><p>Is the rationale for, and objectives of, the study clearly described?</p><p>Yes</p><p>Are sufficient details of the methods provided to allow replication by others?</p><p>Yes</p><p>Are the datasets clearly presented in a useable and accessible format?</p><p>Yes</p><p>Reviewer Expertise:</p><p>I work on parasitology.</p><p>I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard.</p></body></sub-article><sub-article article-type="reviewer-report" id="report50447"><front-stub><article-id pub-id-type="doi">10.21956/openreseurope.20870.r50447</article-id><title-group><article-title>Reviewer response for version 1</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Rajamanikam</surname><given-names>Arutchelvan</given-names></name><xref rid="r50447a1" ref-type="aff">1</xref><role>Referee</role><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3280-1617</contrib-id></contrib><aff id="r50447a1">
<label>1</label>University Malaya, Kuala Lumpur, Malaysia</aff></contrib-group><author-notes><fn fn-type="COI-statement"><p>
<bold>Competing interests: </bold>No competing interests were disclosed.</p></fn></author-notes><pub-date pub-type="epub"><day>25</day><month>2</month><year>2025</year></pub-date><permissions><copyright-statement>Copyright: &#x000a9; 2025 Rajamanikam A</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access peer review report distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><related-article related-article-type="peer-reviewed-article" ext-link-type="doi" id="relatedArticleReport50447" xlink:href="10.12688/openreseurope.19281.1">Version 1</related-article><custom-meta-group><custom-meta><meta-name>recommendation</meta-name><meta-value>approve</meta-value></custom-meta></custom-meta-group></front-stub><body><p>The article is timely to systematically review the literature on the complex and controversial subject of &#x000a0;clinical outcome due to
<italic toggle="yes">Blastocystis</italic>. This scoping review is concise and all encompassing. However, there could be more evidence on pathogenic characteristics in
<italic toggle="yes">Blastocystis</italic>, based on previous studied could have been included.&#x000a0;</p><p> Otherwise, the write-up is clear and serves its purpose.</p><p>Is the study design appropriate for the research question?</p><p>Yes</p><p>Is the rationale for, and objectives of, the study clearly described?</p><p>Yes</p><p>Are sufficient details of the methods provided to allow replication by others?</p><p>Yes</p><p>Are the datasets clearly presented in a useable and accessible format?</p><p>Not applicable</p><p>Reviewer Expertise:</p><p>Diagnostic Parasitology, Host-parasite interaction</p><p>I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard.</p></body></sub-article><sub-article article-type="reviewer-report" id="report50443"><front-stub><article-id pub-id-type="doi">10.21956/openreseurope.20870.r50443</article-id><title-group><article-title>Reviewer response for version 1</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Lepczy&#x00144;ska</surname><given-names>Ma&#x00142;gorzata</given-names></name><xref rid="r50443a1" ref-type="aff">1</xref><role>Referee</role><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5289-6975</contrib-id></contrib><aff id="r50443a1">
<label>1</label>University of Warmia and Mazury, &#x0017b;o&#x00142;nierska, Poland</aff></contrib-group><author-notes><fn fn-type="COI-statement"><p>
<bold>Competing interests: </bold>No competing interests were disclosed.</p></fn></author-notes><pub-date pub-type="epub"><day>14</day><month>2</month><year>2025</year></pub-date><permissions><copyright-statement>Copyright: &#x000a9; 2025 Lepczy&#x00144;ska M</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access peer review report distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><related-article related-article-type="peer-reviewed-article" ext-link-type="doi" id="relatedArticleReport50443" xlink:href="10.12688/openreseurope.19281.1">Version 1</related-article><custom-meta-group><custom-meta><meta-name>recommendation</meta-name><meta-value>approve</meta-value></custom-meta></custom-meta-group></front-stub><body><p>The manuscript is written clearly and is easy to understand. It presents a scoping review protocol, focusing on literature searching strategy for clarifying the current state of knowledge, identifying research gaps, and guiding future research in understanding the relationship between
<italic toggle="yes">Blastocystis</italic> presence and clinical outcomes in humans.</p><p> The introduction of the manuscript highlights the complexity and analytical challenges of determining
<italic toggle="yes">Blastocystis</italic> pathogenicity as well as the sensitivity of detection methods in order to address the conflicting evidence regarding symptomatic and asymptomatic human intestine colonization. The authors underline the high genetic diversity of
<italic toggle="yes">Blastocystis</italic>&#x02014;up to 44 subtypes (STs). Each subtype may have a different, direct or indirect, influence on human health (e.g., through various interactions with the gut microbiota). The interplay between
<italic toggle="yes">Blastocystis</italic> subtypes, the host immune response, and the gut microbiota is believed to play a critical role in determining its impact on human health.</p><p> According to the available literature, it is impossible to state clearly whether
<italic toggle="yes">Blastocystis</italic> is a pathogen or a commensal/beneficial organism to the human gut. In the paper, the authors provided a protocol for conducting a scoping review to assess which data should be taken into consideration in case of performing a review of all accessible studies on human subjects, focusing on the association between
<italic toggle="yes">Blastocystis</italic> presence and various clinical outcomes.</p><p> The scoping review protocol clearly describes and explains the purpose of the selection process of published research regarding the evidence on the relationship between
<italic toggle="yes">Blastocystis</italic> occurrence and human disease, the performance and accuracy of diagnostic methods used for
<italic toggle="yes">Blastocystis</italic> detection, and the treatment and management options for
<italic toggle="yes">Blastocystis</italic>. The manuscript presents the assumptions of the proposed protocol in an accessible and concise way, emphasizing the importance of the systematic search methods.</p><p> The protocol adequately explained, point by point, defined criteria of inclusion and exclusion of published articles, essential for the given objectives. I consider this protocol extremely important. There are a lot of scientific articles in the recent literature; however, many of them do not provide reliable results&#x02014;basing on a small study population (or case reports), reporting the patients symptoms without any confirmation of a physician (as
<italic toggle="yes">Blastocystis</italic> infection has been associated with non-specific gastrointestinal symptoms such as abdominal pain, diarrhea, nausea, vomiting, bloating, and anorexia, we actually are not able to say for sure if it is the only cause of reported symptoms), or studies where
<italic toggle="yes">Blastocystis</italic> is not the main focus, targeting other parasitic infections and accidentally detecting
<italic toggle="yes">Blastocystis</italic>, etc. Additionally, the papers containing the methodology of
<italic toggle="yes">Blastocystis</italic> detection, which is based on microscopy, culture, or ELISA tests only, in times of developed molecular techniques giving the subtype distribution results, are not enough.</p><p> The authors rightly highlight the crucial importance of findings that will provide a comprehensive evidence map, providing future study in understanding the nature of
<italic toggle="yes">Blastocystis</italic> (helping to unravel what factors determine asymptomatic colonization or symptomatic disease), thereby clearly demonstrating the appropriateness of creating a schedule of literature searching.</p><p> The authors pointed to the databases that will be searched and clearly defined the studies selection process (screening and eligibility assessment by two or three reviewers), as well as the eligibility criteria (in the table). At the end, the authors also clarify how the proposed protocol will identify and fill possible gaps in existing knowledge, and according to that, recommendations for future studies will be provided. As a result of the scoping review according to the created protocol, identified and included studies will be presented in two different (tabular and graphical) forms, offering a complete evidence map on the mentioned topic.</p><p>Is the study design appropriate for the research question?</p><p>Yes</p><p>Is the rationale for, and objectives of, the study clearly described?</p><p>Yes</p><p>Are sufficient details of the methods provided to allow replication by others?</p><p>Yes</p><p>Are the datasets clearly presented in a useable and accessible format?</p><p>Not applicable</p><p>Reviewer Expertise:</p><p>medical parasitology (mainly Blastocystis), microbiology, medical biology,medical education</p><p>I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard.</p></body></sub-article></article>